BRPI1009375A2 - derivados inibidores de hsp90, composições que os contém e utilização - Google Patents
derivados inibidores de hsp90, composições que os contém e utilizaçãoInfo
- Publication number
- BRPI1009375A2 BRPI1009375A2 BRPI1009375A BRPI1009375A BRPI1009375A2 BR PI1009375 A2 BRPI1009375 A2 BR PI1009375A2 BR PI1009375 A BRPI1009375 A BR PI1009375A BR PI1009375 A BRPI1009375 A BR PI1009375A BR PI1009375 A2 BRPI1009375 A2 BR PI1009375A2
- Authority
- BR
- Brazil
- Prior art keywords
- compositions containing
- hsp90 inhibitor
- inhibitor derivatives
- derivatives
- hsp90
- Prior art date
Links
- 239000003481 heat shock protein 90 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Psychology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0901274A FR2943341B1 (fr) | 2009-03-19 | 2009-03-19 | Nouveaux derives d'indazole inhibiteurs d'hsp90,compositions les contenant et utilisation |
| FR1050341A FR2955323B1 (fr) | 2010-01-19 | 2010-01-19 | Nouveaux derives d'indazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
| PCT/FR2010/050483 WO2010106290A1 (fr) | 2009-03-19 | 2010-03-18 | Derives d'indazole inhibiteurs d'hsp90, compositions les contenant et utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI1009375A2 true BRPI1009375A2 (pt) | 2016-03-15 |
Family
ID=42313103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1009375A BRPI1009375A2 (pt) | 2009-03-19 | 2010-03-18 | derivados inibidores de hsp90, composições que os contém e utilização |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20120010241A1 (pt) |
| EP (1) | EP2408762A1 (pt) |
| JP (1) | JP2012520859A (pt) |
| KR (1) | KR20110128942A (pt) |
| CN (1) | CN102439003A (pt) |
| AR (1) | AR075874A1 (pt) |
| AU (1) | AU2010224652A1 (pt) |
| BR (1) | BRPI1009375A2 (pt) |
| CA (1) | CA2755660A1 (pt) |
| IL (1) | IL215139A0 (pt) |
| MX (1) | MX2011009806A (pt) |
| RU (1) | RU2011142151A (pt) |
| SG (1) | SG174466A1 (pt) |
| TW (1) | TW201038553A (pt) |
| UY (1) | UY32505A (pt) |
| WO (1) | WO2010106290A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102471335B (zh) | 2009-07-10 | 2015-09-30 | 大鹏药品工业株式会社 | 氮杂二环式化合物或其盐 |
| ES2589557T3 (es) * | 2011-01-07 | 2016-11-15 | Taiho Pharmaceutical Co., Ltd. | Nuevos derivados de indol o indazol y sales de los mismos |
| MX2013007938A (es) | 2011-01-07 | 2013-11-01 | Taiho Pharmaceutical Co Ltd | Compuesto biciclico novedoso o sal del mismo. |
| US20150051203A1 (en) * | 2012-03-28 | 2015-02-19 | Synta Pharmaceuticals Corp. | Triazole derivatives as hsp90 inhibitors |
| RU2645344C2 (ru) * | 2012-05-18 | 2018-02-21 | Санофи | Производные пиразола и их применение в качестве lpar5 антагонистов |
| EP2951153B1 (en) * | 2013-02-01 | 2019-04-03 | Regenacy Pharmaceuticals, LLC | Selective hdac3 inhibitors |
| DE102017008073A1 (de) * | 2017-08-28 | 2019-02-28 | Henkel Ag & Co. Kgaa | Neue anionische Tenside und Wasch- und Reinigungsmittel, welche diese enthalten |
| WO2023207447A1 (zh) * | 2022-04-28 | 2023-11-02 | 腾讯科技（深圳）有限公司 | 吡咯并[2,3-d]嘧啶或吡唑并[3,4-d]嘧啶衍生物及其用途 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6353007B1 (en) * | 2000-07-13 | 2002-03-05 | Boehringer Ingelheim Pharmaceuticals, Inc. | Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| WO2003027085A2 (en) * | 2001-09-26 | 2003-04-03 | Bayer Pharmaceuticals Corporation | 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| US7297709B2 (en) * | 2003-05-22 | 2007-11-20 | Abbott Laboratories | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors |
| MX2007010227A (es) * | 2005-02-25 | 2007-11-07 | Serenex Inc | Derivados de tetrahidroindolona y tetrahidroindazolona. |
| JP2007145786A (ja) * | 2005-11-30 | 2007-06-14 | Toray Ind Inc | ピラジン誘導体及びそれを有効成分とする腎炎治療薬 |
| EP1991540A1 (en) * | 2006-02-21 | 2008-11-19 | Amgen Inc. | Cinnoline derivatives as phosphodiesterase 10 inhibitors |
| WO2007114763A1 (en) * | 2006-03-31 | 2007-10-11 | Astrazeneca Ab | Sulphonamide derivates as modulators of the glucocorticoid receptor |
| US7678803B2 (en) * | 2006-08-24 | 2010-03-16 | Serenex, Inc. | Quinazoline derivatives for the treatment of cancer |
-
2010
- 2010-03-18 BR BRPI1009375A patent/BRPI1009375A2/pt not_active IP Right Cessation
- 2010-03-18 US US13/257,516 patent/US20120010241A1/en not_active Abandoned
- 2010-03-18 EP EP10715951A patent/EP2408762A1/fr not_active Withdrawn
- 2010-03-18 MX MX2011009806A patent/MX2011009806A/es not_active Application Discontinuation
- 2010-03-18 KR KR1020117024518A patent/KR20110128942A/ko not_active Withdrawn
- 2010-03-18 CN CN2010800219733A patent/CN102439003A/zh active Pending
- 2010-03-18 AU AU2010224652A patent/AU2010224652A1/en not_active Abandoned
- 2010-03-18 SG SG2011067634A patent/SG174466A1/en unknown
- 2010-03-18 JP JP2012500297A patent/JP2012520859A/ja active Pending
- 2010-03-18 RU RU2011142151/04A patent/RU2011142151A/ru not_active Application Discontinuation
- 2010-03-18 WO PCT/FR2010/050483 patent/WO2010106290A1/fr active Application Filing
- 2010-03-18 CA CA2755660A patent/CA2755660A1/fr not_active Abandoned
- 2010-03-18 AR ARP100100858A patent/AR075874A1/es not_active Application Discontinuation
- 2010-03-18 TW TW099108049A patent/TW201038553A/zh unknown
- 2010-03-19 UY UY0001032505A patent/UY32505A/es not_active Application Discontinuation
-
2011
- 2011-09-14 IL IL215139A patent/IL215139A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2011009806A (es) | 2011-09-29 |
| IL215139A0 (en) | 2011-12-29 |
| EP2408762A1 (fr) | 2012-01-25 |
| UY32505A (es) | 2010-10-29 |
| RU2011142151A (ru) | 2013-04-27 |
| US20120010241A1 (en) | 2012-01-12 |
| WO2010106290A1 (fr) | 2010-09-23 |
| SG174466A1 (en) | 2011-10-28 |
| JP2012520859A (ja) | 2012-09-10 |
| CN102439003A (zh) | 2012-05-02 |
| AU2010224652A1 (en) | 2011-10-13 |
| KR20110128942A (ko) | 2011-11-30 |
| AR075874A1 (es) | 2011-05-04 |
| TW201038553A (en) | 2010-11-01 |
| CA2755660A1 (fr) | 2010-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2456310A4 (en) | SUBSTITUTED BENZOIMIDAZOLSULFONAMIDES AND SUBSTITUTED INDOLSULFONAMIDES AS MGLUR4 POTENTIATORS | |
| SMT201400179B (it) | 1,2,5-Ossadiazoli come inibitori di indoleamina 2,3-diossigenasi | |
| DK2421825T3 (da) | Azetidinyldiamider som monoacylglycerollipase-inhibitorer | |
| DK2144889T3 (da) | Quinazolin-oxim derivater som HSP90 inhibitorer | |
| HRP20160579T1 (hr) | Spoj indola i njegova farmaceutska upotreba | |
| BRPI0906980A2 (pt) | Composição de derivados e maleatados | |
| BRPI1010567A2 (pt) | composições sublinguais de dexmedetomidina e métodos de uso e aparelho que os emprega | |
| BR112014010650A2 (pt) | inoculantes microbianos e composições fertilizantes que compreendem os mesmos | |
| EP2170076A4 (en) | 4-CARBOXYBENZYLAMINO DERIVATIVES AS HISTONE DEACETYLASE INHIBITORS | |
| IL222484A0 (en) | Arginase inhibitor compounds, compositions comprising the same and uses thereof | |
| BRPI0906598A2 (pt) | Oxim derivattivos como inibidores hsp90 | |
| BRPI0908792A2 (pt) | Composição, e, uso de uma combinação | |
| PT2585437E (pt) | Compostos de tioacetato, composições e métodos de uso | |
| BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
| HRP20180718T1 (hr) | Oligopeptidni spojevi i njihova upotreba | |
| BRPI1013421A2 (pt) | composição parasticida tópica, e, uso de uma composição | |
| BR112012003977A2 (pt) | composições que induzem ajuda de célula t | |
| BRPI1014316A2 (pt) | composição, e, uso de uma composição | |
| BR112013006016A2 (pt) | compostos de azabenzotiazol, composições e métodos de uso | |
| FI20096058A0 (fi) | Koostumuksia ja niihin liittyviä menetelmiä ja käyttöjä | |
| BRPI1009375A2 (pt) | derivados inibidores de hsp90, composições que os contém e utilização | |
| BRPI0917661A2 (pt) | produto que contém macitentan, composição farmacêutica que o contém e uso de macitentan | |
| DE112009000578A5 (de) | Reibahle | |
| CR10879A (es) | Cyclized derivatives as eg-5 inhibitors | |
| BR112012000831A2 (pt) | compostos, composições farmacêuticas e métodos relacionados |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2369 DE 31-05-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |